Sukumar Nagendran
President at Taysha Gene Therapies, Inc. (TSHA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 10SEC | TSHATaysha Gene Therapies, Inc. | Sell Plan | 200,000936,410 held (−18%) | $6.24 | $1.2M | -28.0% |
| Apr 13SEC | TSHATaysha Gene Therapies, Inc. | Sell Plan | 200,0001,136,410 held (−15%) | $4.46 | $892K | +0.7% |
| Jan 27SEC | TSHATaysha Gene Therapies, Inc. | Sell | 89,1321,344,307 held (−6%) | $4.75 | $423K | -5.5% |
| Jan 27SEC | TSHATaysha Gene Therapies, Inc. | Sell | 26,9181,317,389 held (−2%) | $4.61 | $124K | -2.6% |
| Jan 14SEC | TSHATaysha Gene Therapies, Inc. | Sell Plan | 200,0001,006,439 held (−17%) | $4.71 | $942K | -4.7% |
| Dec 1SEC | TSHATaysha Gene Therapies, Inc. | Sell | 110,1251,006,439 held (−10%) | $4.75 | $523K | -5.5% |
| Dec 1SEC | TSHATaysha Gene Therapies, Inc. | Sell | 260,0471,006,439 held (−21%) | $4.51 | $1.2M | -0.4% |
- Sell
President Sukumar Nagendran sold $1.2M of TSHA at $6.24 — pre-scheduled 10b5-1 plan sale.
- Sell
President Sukumar Nagendran sold $892K of TSHA at $4.46 — pre-scheduled 10b5-1 plan sale.
- Sell
President Sukumar Nagendran sold $942K of TSHA at $4.71 — pre-scheduled 10b5-1 plan sale.